На главную
Результаты поиска “Esophageal cancer algorithm for diagnosis”
New evolutions for the neo-adjuvant and adjuvant treatment of esophageal cancer
 
21:34
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Florian Lordick discusses new evolutions for the neo-adjuvant and adjuvant treatment of esophageal cancer. Earn CME credit for related activities at http://elc.imedex.com © 2017 Imedex, LLC.
Просмотров: 894 ImedexCME
Tips, Tricks and Diagnosis of Early Esophageal Barrett's Cancer
 
16:20
presented by Prof. Raf Bisschops
Просмотров: 198 EndoSwiss Channel
Dysphagia Part 1 of 2
 
06:41
This video tutorial discusses the diagnosis and full management of patients presenting with Dysphagia. It is part 1 of a 2 part series. Topics covered in this algorithm include: -Achalasia -Esophageal Cancer -Diffuse Esophageal Spasm "Nutcracker Esophagus"
Просмотров: 23203 josephmedman
Dysphagia Diagnostic Algorithm
 
01:02
With dysphagia, we’ll be looking at an algorithm, and with the algorithm, the objective of this slide is to show you the behavior of the dysphagia. If it’s solid food only that the patient is suffering or experiencing dysphagia to, what kind of differential… what kind of description would you then call it? Let’s talk about intermittent at first. Intermittent to you would mean that there is a fixed obstruction in which the caliber of the esophagus is becoming a little bit more narrowed making it difficult for solid food to then transit through the esophagus. What if the patient says, “Hey Doc, I’m having a hard time eating”, “Oh, tell me about this difficulty that you’re having with eating. Is it with solids? Liquids? Tell me about how that occurs. Is it solids?" “Yeah, I’m having a hard time with solids." “Okay." “But you know what Doc, I would say about a year ago I was having difficulty with solids but then I noticed that now that I think about it, I was having a hard time with drinking milkshakes couple months later." “Hmm." “And then it got to a point where I was having a hard time you know, just about getting anything through." That’s progressive. Progressive. See, initially the patient was having a hard time getting solids through because of the bulky nature of it. And as this obstruction started growing within the esophagus, was making it more difficult for other substances to pass through as the substance got thinner and thinner and thinner referring to the fact that you’re moving from solids towards liquid, and as the obstruction is getting bigger. Common sense.
Просмотров: 1176 Apotheke
Case Discussions: Neo-adjuvant/Adjuvant treatment in gastric cancer: Optimal approach in 2017?
 
21:48
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Ian Chau utilizes a series of case discussions to elucidate whether neo-adjuvant or adjuvant therapy is the most optimal approach for the treatment of gastric cancer. Earn CME credit for related activities at http://elc.imedex.com © 2017 Imedex, LLC.
Просмотров: 601 ImedexCME
Classification Guidelines for Gastric/GEJ Cancers
 
05:39
Yelena Y. Janjigian, MD, differentiates between esophageal, GEJ, and gastric cancers, providing insight on the available classification guidelines.
Просмотров: 448 OncLiveTV
Modalities used to evaluate the differential diagnosis of refractory pouchitis
 
21:36
In this presentation from the Clinical Track at the 2017 Advances in Inflammatory Bowel Diseases conference, Dr. Bo Shen discusses the modalities used to evaluate the differential diagnosis of refractory pouchitis. Earn CME credit for this activity at the following location: https://elc.imedex.com/ELC/Specialty-Search.aspx?search=7275 © 2017 Imedex, LLC.
Просмотров: 193 ImedexCME
Multidisciplinary Management and Repair of a Traumatic Posterior Membranous Tracheal Tear
 
20:35
Learn more: https://www.ctsnet.org/article/multidisciplinary-management-and-repair-traumatic-posterior-membranous-tracheal-tear
Просмотров: 1809 CTSNetVideo
Keynote Lecture: Progress in unraveling the molecular taxonomy in oesophageal and gastric cancer
 
28:54
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Patrick Tan delivers the Keynote Lecture on recent progress in unraveling the molecular taxomonmy in esophageal and gastric cancers. Earn CME credit for a related activity at the following location: http://elc.imedex.com/ © 2018 Imedex, LLC.
Просмотров: 42 ImedexCME
Diagnostic work-up & staging for early gastric cancer
 
12:52
This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Motohiko Kato during the MIS vs Endolumenal Approaches for Early Gastric Cancer on April 13 2018
New treatment approaches for advanced, unresectable HCC
 
21:17
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Jordi Bruix discusses novel treatment approaches for patients with advanced, unresectable hepatocellular carcinoma (HCC). Earn CME credit for a related activity at the following location: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=gastrointestinal © 2017 Imedex, LLC.
Просмотров: 285 ImedexCME
Debate: Optimal pre-op therapy for esophagus and GE junction cancers - Combination chemo and RT
 
12:27
There have been tremendous advancements in the multidisciplinary management of GI cancers in the past decade, with a growing number of new and improved targeted agents and efficacious combination regimens yielding substantial clinical benefits in both early and late stages of the diseases. Moreover, breakthroughs in molecular profiling, cancer immunology, early stage detection, and novel diagnostic techniques have led to accelerated strides in GI cancer research and management. As the field of GI malignancies is continuously evolving, community oncologists must strive to keep abreast of the latest developments and resolve new issues in optimizing the management of esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. To this end, this webcast highlights the clinically significant information presented during the 2016 Great Debates and Updates in GI Malignancies in New York, New York from April 1-2, 2016. In this presentation, Dr. David H. Ilson argues that the optimal pre-operative therapy for esophagus and GE junction cancers is combination chemotherapy and radiotherapy. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205 © 2016 Imedex, LLC.
Просмотров: 87 ImedexCME
Gastric/GEJ Cancers: Non-Immunotherapeutic Advancements
 
05:42
Alan P. Venook, MD, and Yelena Y. Janjigian, MD, shed light on the emerging chemotherapeutic and targeted approaches for the treatment of advanced gastric and gastroesophageal junction cancers.
Просмотров: 176 OncLiveTV
Molecular subtyping/profiling of upper-GI cancers
 
24:38
There have been tremendous advancements in the multidisciplinary management of GI cancers in the past decade, with a growing number of new and improved targeted agents and efficacious combination regimens yielding substantial clinical benefits in both early and late stages of the diseases. Moreover, breakthroughs in molecular profiling, cancer immunology, early stage detection, and novel diagnostic techniques have led to accelerated strides in GI cancer research and management. As the field of GI malignancies is continuously evolving, community oncologists must strive to keep abreast of the latest developments and resolve new issues in optimizing the management of esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. To this end, this webcast highlights the clinically significant information presented during the 2016 Great Debates and Updates in GI Malignancies in New York, New York from April 1-2, 2016. In this presentation, Dr. Josep Tabernero discusses the molecular subtyping/profiling of upper-GI cancers. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205 © 2016 Imedex, LLC.
Просмотров: 215 ImedexCME
Controversy Debate 3: Neo-adjuvant/Adjuvant treatment in gastric cancer - The EU view
 
10:49
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the world convened in Barcelona, Spain from 29 June - 2 July 2016 to present, discuss, and debate the latest advances, treatment strategies, and guidelines for the treatment of gastrointestinal malignancies. In this presentation, Dr. March Ychou provides the EU perspective on neo-adjuvant/adjuvant treatment in gastric cancer. © 2016 Imedex, LLC.
Просмотров: 295 ImedexCME
Are All Gastric Cancers Identical? - Dr. Manish Shah
 
18:09
Dr. Manish Shah presents at the 2012 World Congress on Gastrointestinal Cancer. This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations. Earn accreditation for this activity at http://elc.imedex.com/ELC/Activity-Detail.aspx?activityid=6218 © 2012 Imedex, LLC
Просмотров: 566 ImedexCME
Keynote lecture 3: Carcinogenesis and molecular events in gastric cancer
 
29:14
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast includes most of the clinical presentations from this premier meeting. Didactic lectures, case studies, debates, and cutting-edge research from expert international faculty comprise the outstanding content of the World Congress. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Detail.aspx?activityid=6822 © 2013 Imedex, LLC.
Просмотров: 1753 ImedexCME
Classification of Gastric and Gastroesophageal Junction Cancers
 
07:54
Panelists Johanna Bendell, MD; Ian Chau, MD, FRCP; Yelena Janjigian, MD; and Manish A. Shah, MD, discuss the latest information on classification of gastroesophageal cancers.
Просмотров: 605 OncLiveTV
How to do MSI testing?
 
21:33
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Pierre Laurent-Puig discusses the utilization of MSI testing in the treatment of gastrointestinal malignancies. Earn CME credit for related activities at http://elc.imedex.com © 2017 Imedex, LLC.
Просмотров: 926 ImedexCME
12-1 - Jatin P Shah -  Treatment for Differentiated Cancer (Part 1)
 
15:01
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Просмотров: 6354 StatementsCancer
A single blood test can detect 8 types of cancer
 
03:45
A single blood test can detect 8 types of cancer Researchers have developed a new blood test that can detect eight common types of cancer, including the notoriously elusive liver and pancreatic cancers. Some day, doctors may be able to use this method to spot cancers in their early stages — before the onset of symptoms — thus improving patients' chances of successful treatment and survival. The test, called CancerSEEK, looks for a number of compounds in the blood that are thought to be early signs of cancer. These include 16 different cancer "driver genes" — genes that are associated with tumors — and eight proteins, according to the study describing the test, which was published Jan. 18 in the journal Science. "The sort of ultimate vision is that at the same time that you are getting your cholesterol checked when you are getting your annual physical, you will also get your blood screened for cancer," said lear] What's more, the test appears to be able to screen for five cancers for which screening tests aren't currently available: ovarian, stomach, esophageal, liver and pancreatic. These cancers typically don't cause symptoms until they reach more advanced stages of the disease, when treatment becomes difficult. Liquid biopsies so-called "liquid biopsy" tests — tests that look for markers of cancer in the blood — is the use of two types indicators (genes and p The test uses an artificial-intelligence algorithm to analyze the combinations of genes and protein biomarkers found in the blood sample and identify which type of cancer the patient likely has, Cohen said. The tool could be particularly important for general practitioners, who could administer the test and then send their patient for additional testing to verify the result, he said. For example, if the blood-test results suggest stomach cancer, a doctor could recommend the patient get an endoscopy to confirm the results, Cohen said. Similarly, test results pointing to colon cancer could lead to a colonoscopy. To study how well the blood test worked, the researchers tried it on about 1,000 patients with known diagnoses of cancer that hadn't metastasized, or spread to other parts of the body. These cancers included breast, ovarian, stomach, liver, pancreatic, esophageal, colorectal and lung. The researchers also enrolled about 800 healthy patients without cancer to serve as a control group. The test detected cancer with 69 to 98 percent accuracy, the study found. And the more advanced the cancer, the higher the accuracy. But for cancers in an early stage — for example, stage one cancers — the test accurately detected cancer just 40 percent of the time. Independent experts see this relatively low figure as the major weakness of the test. [7 Cancers You Can Ward Off with Exercise] Low sensitivity? "The sensitivity of the test in stage one cancer is quite low, about 40 percent," said Dr. Mangesh Thorat, deputy director of the Barts Clinical Trials Unit at the Center for Cancer Prevention at Queen Mary University of London. Thorat was not involved in the new study. "Even with stage one and two combined, it appears to be around 60 percent," Thorat told Live Science. "So the test will still miss a large proportion of cancers at the stage where we want to diagnose them." The blood test also detected cancer in 1 percent of the control group, according to the study. This could either mean that the test has a 1 percent false-positive rate (in other words, it falsely points to cancer 1 percent of the time) or that the individuals do in fact have cancer that has not yet been diagnosed, Cohen said. "The test needs to be validated in a large-scale study that would evaluate tens of thousands of healthy individuals to confirm the sensitivity and specificity," Cohen said. "It's really important to confirm the results and demonstrate that this test would work in a real-world" setting. Cohen said the researchers want to increase the sensitivity and accuracy of the test by including additional types of biomarkers. #blood_test_for_cancer #inside_human_channel #cancer_symptoms#cancer_stages #blood_test_to_detect_cancer #types_of_cancer#cancer_facts #hashem_al_ghalilli_videos ====================================== TO_OWNERS_AND_COPYRIGHT: This channel is created to promote the best informative videos releated Health Technology Science nature performers,and producers. We do not want to violate copyrights. IF_YOU_WANT_TO_DELETE_THIS_VIDEO, please let us know - we can immediately remove it from our channel. insidehuman@gmail.com this_video_credit_goes_to Hashem Al Ghailli youtube channel https://www.youtube.com/user/hashemalghaili facebook https://www.facebook.com/ScienceNaturePage/ subscribe our channel for more informative videos https://www.youtube.com/channel/UC4GrKzQc0n-i8DsjH_ynkNA?view_as=subscriber Google plus https://plus.google.com/102332871130341184209
Просмотров: 54 Inside Human
GASTROESOPHAGEAL REFLUX DISEASE -- DYSPHAGIA
 
37:05
GASTRO ESOPHAGEAL REFLUX DISEASE- DYSPHAGIA • Dear viewers, • Greetings from “Surgical Educator” • Today I have uploaded a common GI problem in the society- GERD • GERD is retrograde flow of stomach contents into esophagus • GERD cause dysphagia only if it is complicated with a stricture formation • I have discussed the definition, etiology, pathology, clinical features, complications, investigations, treatment, mind map, diagnostic & treatment algorithms of GERD • I hope you will enjoy the video. • You can watch all my surgery teaching videos in the following links • surgicaleducator.blogspot.com youtube.com/c/surgicaleducator • Thank you for watching the video.
Просмотров: 247 Surgical Educator
Debate 6: Optimal Pre-op Therapy for Esophagus and GE junction Cancers - Chemo alone
 
12:50
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the management of gastrointestinal malignancies. Join us as nationally-recognized thought leaders take opposing sides on topics of clinical interest, and present updates in standards of care. In this presentation, Dr. Eric Van Cutsem argues that chemotherapy alone is the preferred threatment for pre-op esophagus and GE junction cancer patients. © 2015 Imedex, LLC.
Просмотров: 136 ImedexCME
COLORECTAL CARCINOMA-  Lower GI Hemorrhage
 
31:03
Dear Viewers, Greetings from " Surgical Educator" Today in this video I am going to talk on one more cause for Lower GI hemorrhage- Colorectal Carcinoma. I talk on the various causes for Lower GI hemorrhage, Etiopathogenesis, clinical features, investigations, staging, treatment and followup of Colorectal carcinoma. I have also included a mindmap, a diagnostic algorithm and a treatment algorithm. Hope you will enjoy the video. You can watch the video in the following links: surgicaleducator.blogspot.com youtube.com/c/surgicaleducator Thank you for watching the video.
Просмотров: 2418 Surgical Educator
Barretts Esophagus, Dysplasia-Mayo Clinic
 
01:23
Barretts esophagus is a condition in which damaged cells in the esophagus become more like cells found in the intestine, usually as a result of GERD or acid reflux, in a process called metaplasia. Over time, those cells might become more abnormal. Dysplasia is a word that describes cells with a higher risk of developing into cancer. This video explains low-grade dysplasia and high-grade dysplasia. Mayo Clinic has a very large team with an international reputation for its skill in diagnosing and treating reflux, Barretts esophagus and esophagus cancer. For more information, go to the Mayo Clinic website, http://www.mayoclinic.org/barretts-esophagus/
Просмотров: 3521 Mayo Clinic
Esophageal atresia - Treatment - Pediatric Playbook
 
04:54
http://www.childrenshospital.org/eat You may have heard that esophageal atresia can be challenging to treat. Unfortunately, that's true. But the dedicated, compassionate staff at Boston Children's Hospital is incredibly well-qualified to care for your child. We're known for our science-driven approach—we're home to the most extensive research enterprise located in a pediatric hospital in the world, and we partner with a number of top biotech and health care organizations—but we never forget that your child is a child, and not just a patient. The best treatment for esophageal atresia is usually surgery to connect the ends of the esophagus together. But in long-gap esophageal atresia, the ends are often too far apart to be easily connected. Traditionally, babies with this type of long-type atresia are treated in ways that require life-long care and monitoring, such as pulling up the stomach to connect directly to the end of the esophagus (gastric pull-ups), or creating more "esophagus" from a piece of the child's large intestine (colonic transposition).
Просмотров: 16877 Boston Children's Hospital
CHEST PAIN: Myocardial Infarction (MI) or Esophageal Spasm?
 
08:01
Millions of patients present to the Emergency Room with chest pain. Even women have heart attacks, and this is important to remember. There is a standard protocol, like a list of the same things that you do every time, for every patient. Each facility may have its own Protocol, but it really is not that hard. History of Chest Pain: sudden? aching? stabbing? twisting? Vital Signs: Respiratory Rate; RR =16 (Normal = 8 - 10). BP (Blood Pressure) = 130/78 mmHg; HR (Heart Rate) = 90 bpm. Temp = normal. What to do? Go through an algorithm in your head. Same steps each time, for millions of patients across the USA and the world. You are like a car mechanic (i.e., the science of medicine) and a magician (the art of medicine) in one. Just remember what to do, and your patient will get good care for what ever the diagnosis. Remember that History is 99% of the diagnosis, so obviously some one with a previous MI would be at increased risk of morbidity and/or mortality. In this case, you really better remember how this Algorithm goes. Oh.....and don't forget to be polite, especially when there are children in the room.
Просмотров: 12333 VirtualMedSchool1
Debate 6: Optimal Pre-op Therapy for Esophagus and GE junction Cancers - Chemoradiotherapy
 
12:29
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the management of gastrointestinal malignancies. Join us as nationally-recognized thought leaders take opposing sides on topics of clinical interest, and present updates in standards of care. In this presentation, Dr. Michael G. Haddock argues that chemoradiotherapy is the preferred treatment for pre-op esophagus and GE junction cancer patients. © 2015 Imedex, LLC.
Просмотров: 420 ImedexCME
Niraj Jani, MD - GBMC Kroh Center for Digestive Disorders - Division of Gastroenterology
 
02:09
GBMC's Kroh Center for Digestive Disorders, under the direction of Niraj D. Jani, MD, Chief of The Division of Gastroenterology, offers a multi-disciplinary approach for the diagnosis and treatment of disorders of the esophagus, stomach, small intestine, colon, pancreas, gallbladder and liver for both adults and children. A full range of diagnostic and therapeutic endoscopic procedures are performed in the center. The Kroh Center for Digestive Disorders at GBMC is among the first in Maryland to introduce a new endoscope platform to screen for colorectal cancer with High-Definition Endoscopy and Narrow Band Imaging (NBI) technologies. High-Definition Endoscopy and NBI enable endoscopists to perform "gold standard" diagnostic procedures to more accurately visualize the entire colon and allow for the early detection and removal of lesions and polyps before they turn into cancer. Capsule endoscopy, rectal and esophageal motility studies and rectal ultrasound, pH studies, endoscopic ultrasound, ablative procedures for Barrett's esophagus, and breath tests are also available. The center is staffed by highly qualified gastroenterologists, surgeons and specialized nurses. Excellent, specialized complimentary services and procedures are also provided by laboratory and radiology departments, as well as other medical and surgical specialties in the hospital.
Просмотров: 2187 Greater Baltimore Medical Center
Biomarkers for treatment selection in colon cancer
 
22:49
There have been tremendous advancements in the multidisciplinary management of GI cancers in the past decade, with a growing number of new and improved targeted agents and efficacious combination regimens yielding substantial clinical benefits in both early and late stages of the diseases. Moreover, breakthroughs in molecular profiling, cancer immunology, early stage detection, and novel diagnostic techniques have led to accelerated strides in GI cancer research and management. As the field of GI malignancies is continuously evolving, community oncologists must strive to keep abreast of the latest developments and resolve new issues in optimizing the management of esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. To this end, this webcast highlights the clinically significant information presented during the 2016 Great Debates and Updates in GI Malignancies in New York, New York from April 1-2, 2016. In this presentation, Dr. Christopher H. Lieu discusses the use of biomarkers for colon cancer treatment selection. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205 © 2016 Imedex, LLC.
Просмотров: 3103 ImedexCME
Present and Future of Barrett's Esophagus and Esophageal Adenocarcinoma Prevention
 
01:01:48
A Division of Gastroenterology Grand Rounds presented by Julian Abrams, MD, MPH, Assistant Professor of Medicine (Gastroenterology), Columbia University College of Physicians & Surgeons
Просмотров: 124 Icahn School of Medicine
Learn About an Endoscopic Mucosal Resection
 
02:24
Dr. Sharmila Anandasabapathy, director of endoscopy at The Mount Sinai Hospital in New York, describes endoscopic mucosal resection. It is typically performed for Barretts esophagus, early cancer of the esophagus, or pre-cancer of the esophagus. During the minimally invasive procedure, polyps or parts of the lining of the esophagus are removed. It is quite effective for the early treatment of cancer.
Просмотров: 1373 Mount Sinai Health System
Neural Network And Esophageal Cancer by EpisolveGI
 
03:44
heck episolvegi.com, a naturally enhanced anatacid. Also check naturalantacid.net Neural Network and Artificial Intelligence can used for better treatment of Esophageal Cancer. Cancer of the esophagus is an increasingly common and extremely lethal. All esophageal cancers are either squamous cell carcinomas or adenocarcinomas.
Просмотров: 6 FamilyIgloo
MSI Testing’s Impact on Immunotherapy in Gastric Cancers
 
05:17
Yelena Y. Janjigian, MD, identifies the role of MSI testing in tangent with immunotherapy for the treatment of advanced gastric and GEJ cancers.
Просмотров: 264 OncLiveTV
Controversy Debate 3: Neo-adjuvant/Adjuvant treatment in gastric cancer - The surgical point of view
 
13:00
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the world convened in Barcelona, Spain from 29 June - 2 July 2016 to present, discuss, and debate the latest advances, treatment strategies, and guidelines for the treatment of gastrointestinal malignancies. In this presentation, Dr. William H. Allum provides the surgeon's perspective on neo-adjuvant/adjuvant treatment in gastric cancer. © 2016 Imedex, LLC.
Просмотров: 194 ImedexCME
USMLE: What you need to know about Barrett's esophagus by usmleTeam
 
02:59
FREE FREE FREE !!! FIGURE1 medical app: Discover medical cases from every specialty their views and advice DOWNLOAD NOW  http://download.figure1.com/greenglobe Prepare for USMLE,UK,CANADIAN,AUSTRALIAN, NURSING & OTHER MEDICAL BOARD examinations around the globe with us.Understand the basics, concepts and how to answer wisely and score 99 in each step. we are here to help you. What are you waiting for subscribe now!!! SUBSCRIBE NOW: http://bit.ly/161OmbF For Business inquiries: allornonelaw4business@gmail.com Join our USMLE step 1 prep Zone : https://www.facebook.com/groups/730000020375744 Join our USMLE CK STUDY GROUP: https://www.facebook.com/groups/320959178079398
Просмотров: 1982 allornonelaw
Current Molecular Profiling in Gastric Cancers
 
08:32
Panelists Johanna C. Bendell, MD; Yelena Y. Janjigian, MD; Kohei Shitara, MD; Ian Chau, MD; and Manish A. Shah, MD, explain the current role for molecular testing in gastroesophageal cancers, with a focus on HER2 and MSI status.
Просмотров: 196 OncLiveTV
Opening Lecture: Pitfalls in imaging for liver tumors
 
17:47
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the world convened in Barcelona, Spain from 29 June - 2 July 2016 to present, discuss, and debate the latest advances, treatment strategies, and guidelines for the treatment of gastrointestinal malignancies. In this presentation, Dr. Jens Ricke discusses the pitfalls in imaging for liver tumors. © 2016 Imedex, LLC.
Просмотров: 821 ImedexCME
MQ074 Gastroenterology   Epigastric Pain
 
34:52
Просмотров: 3475 mas 911
Esophageal atresia lecture by Dr. Foker, Boston Children's Hospital
 
01:09:15
Esophageal atresia lecture by Dr. Foker, Boston Children's Hospital.
Просмотров: 10055 Boston Children's Hospital
Overview of Late-Line Therapies for Metastatic Colorectal Cancer
 
11:00
In Part 1 of the 'Optimizing Dosing Strategy for Late-Line Therapies in mCRC' roundtable discussion, Drs. Grothey, Bekaii-Saab, and Van Cutsem provide an overview of current standards of care for patients with relapsed/refractory metastatic colorectal cancer. Earn CME Credit for this activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7287 © 2018 Imedex, LLC.
Просмотров: 106 ImedexCME
DYSPHAGIA-- INTRODUCTION
 
19:54
DYSPHAGIA- INTRODUCTION Dear Viewers, • Greetings from “Surgical Educator” • Today I am going to start a new series of videos on DYSPHAGIA. • In today’s episode I have talked about the introduction to dysphagia covering the surgical anatomy, physiology of deglutition, causes for dysphagia, symptoms, signs, investigations and diagnostic algorithm. • In the subsequent slides, I will discuss about all important causes of dysphagia one by one. • I hope this series of videos will be very useful to you and you will enjoy them. • You can watch all my Surgical teaching videos in the following links: • surgicaleducator.blogspot.com youtube.com/c/surgicaleducator • Thank you for watching the video.
Просмотров: 423 Surgical Educator
THYROID -  Introduction- Neck Swellings
 
16:06
THYROID - INTRODUCTION Dear Viewers, Greetings from “Surgical Educator” In this episode, I have talked about the introduction to thyroid diseases. I have talked on surgical anatomy, surgical physiology, pathology, symptomatology, and investigations to do in thyroid pathology. In the forthcoming videos, I will talk on benign thyroid diseases and carcinoma thyroid. You can watch this video in the following links: surgicaleducator.blogspot.com youtube.com/c/surgicaleducator Thank you for watching the video.
Просмотров: 2615 Surgical Educator
Diagnosis of GIST by EUS FNB
 
01:05
Просмотров: 470 Jayapal Ramesh
Conquering Cancer with Yelena Janjigian, MD and David Solit, MD
 
04:42
Conquer Cancer Foundation Grantees Yelena Y. Janjigian, MD (2009 YIA, 2013 CDA) and David B. Solit, MD (2001 YIA, 2002 CDA) of Memorial Sloan Kettering Cancer Cancer discuss how CCF grant funding advanced their cancer research and launched their careers. Watch this video to learn about their personal connections to oncology, why mentorship is important, and how receiving a CCF grant is a "rite of passage" for many early-career cancer researchers, such as Dr. Janjigian and Dr. Solit.
Просмотров: 1244 ConquerCancerFdtn
Eradicate Cancer Conference 2018
 
02:31
Eradicate Cancer - Can advanced immunotherapy make it possible? Immunotherapy is rapidly emerging as the core medical platform for the treatment of cancer. Find out more at http://www.eradicatecancer2018.org/
Просмотров: 862 In Vitro Technologies - Life Science
Keynote Lecture 1: Unraveling the taxonomy in gastric cancer
 
34:15
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the world convened in Barcelona, Spain from 29 June - 2 July 2016 to present, discuss, and debate the latest advances, treatment strategies, and guidelines for the treatment of gastrointestinal malignancies. In this Keynote Lecture, Dr. Adam Bass examines the taxonomy in gastric cancer. © 2016 Imedex, LLC.
Просмотров: 1696 ImedexCME